These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 6370882)

  • 1. The role of prostaglandins in Bartter's syndrome.
    Winterborn MH; Hewitt GJ; Mitchell MD
    Int J Pediatr Nephrol; 1984 Mar; 5(1):31-8. PubMed ID: 6370882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bartter's syndrome: urinary prostaglandin E-like material and kallikrein; indomethacin effects.
    Halushka PV; Wohltmann H; Privitera PJ; Hurwitz G; Margolius HS
    Ann Intern Med; 1977 Sep; 87(3):281-6. PubMed ID: 900671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasma and urinary prostaglandins in Bartter's and pseudo-Bartter's syndrome (author's transl)].
    Hornych A
    Nephrologie; 1980; 1(3):113-6. PubMed ID: 6945487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bartter's syndrome: seven cases in siblings. Hypothesis of mild forms (author's transl)].
    Nivet H; Rolland JC; Lebranchu Y; Dray F; Benatre A; Drucker J; Grenier B; Bagros P
    Nouv Presse Med; 1980 Apr; 9(18):1287-90. PubMed ID: 6990383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bartter's syndrome: 10 cases in childhood. Results of long-term indomethacin therapy.
    Dillon MJ; Shah V; Mitchell MD
    Q J Med; 1979 Jul; 48(191):429-46. PubMed ID: 120550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bartter's syndrome: contrasting patterns of prostaglandin excretion in children and adults.
    Dray F
    Clin Sci Mol Med; 1978 Jan; 54(1):115-8. PubMed ID: 620489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A fortultousness association: Bartter's syndrome and chondrocalcinosis (author's transl)].
    Goulon M; Raphael JC; De Rohan P
    Nouv Presse Med; 1980 Apr; 9(18):1291-5. PubMed ID: 7375363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction of increased prostacyclin production in Bartter's syndrome by indomethacin.
    Güllner HG; Cerletti C; Bartter FC; Gill JR; Smith JB
    Trans Assoc Am Physicians; 1980; 93():130-40. PubMed ID: 7018063
    [No Abstract]   [Full Text] [Related]  

  • 9. Bartter's syndrome with normal urinary excretion of prostaglandin E: therapeutic effects of propranolol, spironolactone, indomethacin and potassium chloride.
    Sato M; Abe K; Yasujima M; Otsuka Y; Chiba S; Haruyama T; Yoshinaga K; Saito T; Kabuki J
    Tohoku J Exp Med; 1980 Jun; 131(2):151-9. PubMed ID: 7404582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin synthetase inhibitors in Bartter's syndrome. Effect on immunoreactive prostaglandin E excretion.
    Bowden RE; Gill JR; Radfar N; Taylor AA; Keiser HR
    JAMA; 1978 Jan; 239(2):117-21. PubMed ID: 412983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raised urinary prostaglandins in patient without Bartter's syndrome.
    Nivet H; Grenier B; Rolland JC; Lebranchu Y; Dray F
    Lancet; 1978 Feb; 1(8059):333-4. PubMed ID: 75374
    [No Abstract]   [Full Text] [Related]  

  • 12. [Bartter's syndrome. Failure of aspirin and success of indomethacin].
    Jáuregui WO; Di Fonzo P; Marchissio ML; Roehr E; Hauger-Klevene JH
    Medicina (B Aires); 1979; 39(4):447-56. PubMed ID: 397398
    [No Abstract]   [Full Text] [Related]  

  • 13. Bartter's syndrome: a disorder characterized by high urinary prostaglandins and a dependence of hyperreninemia on prostaglandin synthesis.
    Gill JR; Frölich JC; Bowden RE; Taylor AA; Keiser HR; Seyberth HW; Oates JA; Bartter FC
    Am J Med; 1976 Jul; 61(1):43-51. PubMed ID: 820194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary prostaglandins in Bartter's and pseudo-Bartter's syndrome.
    Hornych A; Krief C; Aumont J
    Uremia Invest; 1985-1986; 9(2):203-10. PubMed ID: 3870249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bartter's syndrome: Recurrence in the course of a treatment inhibiting prostaglandin synthesis].
    Favre L; Glasson P; Flory ED; Dray F; Vallotton MB
    Schweiz Med Wochenschr; 1979 Feb; 109(5):142-7. PubMed ID: 441720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The principal metabolites of arachidonic acid are overproduced in Bartter's syndrome.
    Güllner HG; Smith JB; Bartter FC
    Adv Prostaglandin Thromboxane Res; 1980; 7():1185-7. PubMed ID: 6892749
    [No Abstract]   [Full Text] [Related]  

  • 17. Regulation of urinary prostaglandins in Bartter's syndrome.
    Zipser RD; Rude RK; Zia PK; Fichman MP
    Am J Med; 1979 Aug; 67(2):263-7. PubMed ID: 463932
    [No Abstract]   [Full Text] [Related]  

  • 18. Correction of increased prostacyclin synthesis in Bartter's syndrome by indomethacin treatment.
    Gullner HG; Smith JB; Cerletti C; Gill JR; Bartter FC
    Prostaglandins Med; 1980 Feb; 4(2):65-72. PubMed ID: 6994153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary excretion rate of 6-keto-prostaglandin F1 alpha as an index of circulating prostacyclin.
    Seyberth HW; Müller H; Soeding K; Wille L; Hackenthal E
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():533-8. PubMed ID: 6221575
    [No Abstract]   [Full Text] [Related]  

  • 20. [Bartter's syndrome: the long term effects of indomethacin on growth (author's transl)].
    Floret D; David M; Roux A; Hage GN; Teyssier G
    Nouv Presse Med; 1979 Jan; 8(1):17-21. PubMed ID: 122007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.